EPISODE · Jul 31, 2020 · 26 MIN
S2E4: SFTR Review: Danny Corrigan on SFTR So Far - What Worked & What Needs Fixing
from The REGIS-TR RoundUp · host REGIS-TR
This week former CEO of CME TR Danny Corrigan joins the virtual studio team to review what went well with SFTR over the first weeks since launch, how the UTI issue is working out, where the problems with varying cash and collateral valuations might come from, and whether NCAs will be as flexible about SFTR as they were about EMIR when that first rolled out. Plus we report on how our clients have responded to the challenges of the new regulation...
What this episode covers
This week former CEO of CME TR Danny Corrigan joins the virtual studio team to review what went well with SFTR over the first weeks since launch, how the UTI issue is working out, where the problems with varying cash and collateral valuations might come from, and whether NCAs will be as flexible about SFTR as they were about EMIR when that first rolled out. Plus we report on how our clients have responded to the challenges of the new regulation...
NOW PLAYING
S2E4: SFTR Review: Danny Corrigan on SFTR So Far - What Worked & What Needs Fixing
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m